Predictors of Chronic Obstructive Pulmonary Disease Exacerbation Reduction in Response to Daily Azithromycin Therapy

Rationale: Daily azithromycin decreases acute exacerbations of chronic obstructive pulmonary disease (AECOPD), but long-term side effects are unknown. Objectives: To identify the types of exacerbations most likely to be reduced and clinical subgroups most likely to benefit from azithromycin, 250 mg...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Am J Respir Crit Care Med
Autors principals: Han, MeiLan K., Tayob, Nabihah, Murray, Susan, Dransfield, Mark T., Washko, George, Scanlon, Paul D., Criner, Gerard J., Casaburi, Richard, Connett, John, Lazarus, Stephen C., Albert, Richard, Woodruff, Prescott, Martinez, Fernando J.
Format: Artigo
Idioma:Inglês
Publicat: American Thoracic Society 2014
Matèries:
Original Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4226018/
https://ncbi.nlm.nih.gov/pubmed/24779680
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1164/rccm.201402-0207OC
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars